Baclofen in Parkinson's disease
- PMID: 355602
- PMCID: PMC1083385
- DOI: 10.1136/jnnp.41.8.707
Baclofen in Parkinson's disease
Abstract
In a controlled trial, baclofen (mean dose 45 mg daily) signficantly increased disability from Parkinsonism in 12 patients with the long-term levodopa syndrome. Peak dose choreoathetosis was not improved but benefit was observed in all four patients with "off period dystonia." Adverse side effects were common and severe, and included visual hallucinations, vomiting, and dizziness.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources